Bilaal.Raja
Company record

STTK  Shattuck Labs, Inc.

Trailing twelve months to 2026-06-30, as filed 2026-08-11 and not restated since.
Healthcare

Scale

Market cap
$675m
Revenue TTM
$1m
Net income TTM
$-53m
Free cash flow
—
Composite score
—
Sector rank
#2198

Valuation

P / E
—
EV / EBITDA
—
EV / sales
612.1
FCF yield
—
Yield vs 10-yr
-13.07pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 5.28% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
-5,256.8%
EBITDA margin
-5,222.2%
ROE
-24.9%
ROIC
-37.7%
Revenue growth
-66.6%

Insider activity, last 90 days

Net open-market
$-0.13m
Buyers
1
Sellers
2

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Pursuant to the Kayak Agreement, the Company is also eligible to receive future payments contingent upon the achievement of specified development, regulatory, and commercial milestones of up to $ 86.0 million, and tiered royalties on net sales of any commercialized products subject to the Kayak Agreement in the low single digits. The Sales Agent is generally entitled to compensation at a commission equal to up to 3 % of the aggregate gross sales price per share sold under the Sales Agreement. …Shattuck Labs, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-11

Read the full passage →